Ease-of-Use / Product
September 16, 2026
8
min read

Why Combine a Breath Test With Imaging?

A breath test can't show your doctor where to look, and scanning everyone turns up too much. Used in order, each covers the other's gap.

A halftone image of a dog in profile beside a wave of dots, in Dognosis green

A breath test and a scan answer different questions. A Breath VOC score helps your doctor understand your cancer risk, while imaging shows what is physically in the body and where it sits. Each one struggles when asked to do the other's job, which is why they work best one after the other.

What Does the Dognosis Breath Test Tell Your Doctor?

The test starts with a mask that you breathe into normally for about ten minutes. The sample then comes to our lab, where the dogs assess it and DogOS combines their responses into a Breath VOC score, giving more weight to the dogs that have proven most reliable (the full process is in How the Dognosis Breath Test Uses Canine Brain-Computer Interfaces). A registered medical practitioner reviews every score before it reaches you as Baseline, Medium or Elevated.

That score reflects risk across many cancers at once. In our peer-reviewed Phase II study, published in the Journal of Clinical Oncology in 2026, the approach correctly identified 90.8% of people who had cancer (its sensitivity) and correctly cleared 91.3% of people who didn't (its specificity), across seven cancer groups spanning more than 20 cancer types.

The trade-off for that breadth is that the score carries no location. It tells your doctor that a closer look is worthwhile, without saying which part of the body to look at.

A funnel showing Dognosis Breath Test as the first step, above blood-based tests, organ-specific tests and the standard of care (imaging and biopsy)
Where the Dognosis Breath Test sits in the screening funnel, upstream of imaging and biopsy.

Why Not Just Scan Everyone?

Showing location is exactly what imaging does well. A CT, MRI or PET-CT scan can show a mass, how large it is, which organ it sits in and whether it has spread. That level of detail becomes a problem when scans are pointed at large numbers of people who feel well. Because most of them don't have cancer, most of what the scans pick up turns out to be something harmless, like a cyst or a benign nodule, and each finding still needs follow-up to rule out.

A systematic review of whole-body MRI in adults without symptoms puts a number on this: in the studies that tracked it, about one in six people had a finding that turned out to be a false positive (Kwee and Kwee, Journal of Magnetic Resonance Imaging, 2019). Each of those findings means more appointments, more cost and more worry, plus more radiation for CT and PET-CT. Imaging works best when it's kept for the people most likely to need it.

Can a Breath Test Work on Its Own?

A breath test is one way to pick out those people, but it runs into the same arithmetic from the other side. Its specificity of 91.3% means that around 9 in every 100 people without cancer still get an elevated score. In our study that mattered less, because roughly one in four samples came from someone with cancer, as is typical of a case-control design. In everyday life cancer is far rarer, so those 9 in 100 make up a much larger share of the elevated scores.

To see how much larger, picture 1,000 people taking the test at an annual check-up, five of whom have an undiagnosed cancer (an illustrative number). At the study's figures, four or five of them would get an elevated score, along with around 85 people who don't have cancer. Most elevated scores in a group like this would be false alarms, so an elevated score can only ever be a reason to look closer.

How Do a Breath Test and Imaging Work Together?

Looking closer is where imaging comes back in. If only the roughly 90 people with an elevated score go on to further evaluation, the other 910 or so avoid a scan they didn't need, along with the incidental findings that would have come with it. Among those 90, about one in 20 has cancer, roughly ten times the rate in the original group.

That higher rate changes what a scan finding means. The scanner and the radiologist are the same as before, yet a finding is now far more likely to be real, because the people being scanned were more likely to have cancer to begin with. Statisticians call this a higher positive predictive value. It's why the two tests together do better than either one alone: the breath test narrows the group, and imaging confirms what's there and shows where.

This sequence has already been tried with a blood test as the first step. In the DETECT-A study, around 10,000 women aged 65 to 75 with no history of cancer gave a blood sample, and those whose result came back positive and was confirmed went on to imaging, usually PET-CT. The blood test picked up 26 cancers, while only 1% of participants had a PET-CT because of a false-positive blood test and 0.22% went through an invasive procedure that turned out to be unnecessary (Lennon et al., Science, 2020).

DETECT-A shows the sequence is workable, though the real measure of any approach like this is whether fewer people die of cancer, a bar Siddhartha Mukherjee has argued for in The New Yorker ("The Catch in Catching Cancer Early," June 2025). Our prospective studies, FirstAlert and SANKET, will show how our version of the sequence holds up in real populations.

How Does the Dognosis Membership Work?

Narrowing the group first is the job the Dognosis Breath Test is built for. It comes as the Dognosis membership, which runs for a year. Over that year you take a series of Dognosis Breath Tests, each one reviewed by a registered medical practitioner, with a Care Team looking out for you between tests. Because you're tested more than once while you feel well, your cancer risk gets checked again and again, instead of once or only after symptoms show up. If your Breath VOC score suggests a closer look, your doctor may recommend further evaluation, and the Care Team helps you through what comes next.

The Dognosis Breath Test launches in Bengaluru in early 2027, and you can join the waitlist to be among the first to take it.

The Dognosis Breath Test is not a diagnostic test. It does not diagnose, predict, prevent, cure, treat, mitigate, or monitor cancer or any other disease or disorder.

READY TO TAKE THE NEXT STEP?
Be first in line for the Dognosis Breath Test
Be the first to know when the Dognosis Breath Test is available in your city. No cost, no commitment, just early access.
Join the waitlist

Join the waitlist

Be first to know

We'll reach out the moment Dognosis comes to your city.

★ Early access + 20% off at launch

No cost to join, no commitment.

Join the waitlist

400+ people already on the waitlist